letters & comments

NHC Comments on Patient-Focused Drug Development Guidance: Methods To Identify What Is Important to Patients and Select, Develop, or Modify Fit-for-Purpose Clinical Outcome Assessments

December 14, 2018

Read More

NHC Comments on Accountable Care Organizations Pathways to Success

October 16, 2018

Read More

NHC Comments on FDA Standard Core Clinical Outcome Assessments and Endpoints

October 15, 2018

Read More

Letter to Secretary Azar on the Administration’s Step Therapy Policy

September 26, 2018

Read More

NHC Comments on Medicare Program: Proposed Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs

September 26, 2018

Read More

NHC Comments on the FDA’s Draft Guidance on Patient-Focused Drug Development: Collecting Comprehensive and Representative Input

September 11, 2018

Read More

NHC Comments on the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

July 16, 2018

Read More

NHC Comments on Proposed Rule, Short-Term, Limited-Duration Insurance

April 23, 2018

Read More

Letter to Congress Expressing Concern with Short-Term Limited Duration Plans

April 18, 2018

Read More
1 2 3 4 Next »